HIGHLIGHTS
- who: Hispanic and colleagues from the Department of Pharmacology, School of Medicine, University of Costa Rica, Sede Rodrigo Facio, San Pedro, San Josu00e9, Costa Rica Department of Medicine, NYC, New York, Jacobi Medical Center/Albert Einstein College of Medicine, New York, NY, USA have published the article: Using the Khorana risk score to predict venous thromboembolism and overall survival in a cohort of Hispanic patients with solid malignancies, in the Journal: (JOURNAL) of 31/05/2022
- what: The study has several limitations by its retrospective nature and the inherent confounders and biases associated with such . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.